Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

@article{Booy1992ImmunogenicityAS,
  title={Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.},
  author={Robert Booy and Stephen A. Taylor and Simon R M Dobson and David Isaacs and G. Sleight and S J Aitken and Hugh Griffiths and Helen M. Chapel and Richard T. Mayon-White and J A Macfarlane},
  journal={Archives of disease in childhood},
  year={1992},
  volume={67 4},
  pages={475-8}
}
The immunogenicity and safety of a new Haemophilus influenzae type b conjugate vaccine, PRP-T, was studied in 107 infants from the Oxford district. The vaccine was given concurrently with diphtheria, pertussis, tetanus, and polio vaccines at 2, 3, and 4 months of age. Symptoms after immunisation were recorded by a parent. Sera were obtained before the first immunisation and at 5 months of age and the antibodies were measured by both radioimmunoassay and enzyme linked immunosorbent assay (ELISA… CONTINUE READING